Simultaneous determination of seven index components in<i> Naoxintong</i> capsule by HPLC wavelength switching method

ZHANG Shengjie; WANG Li; TIAN Zhimei

doi:10.11665/j.issn.1000-5048.20190510

Journal of China Pharmaceutical University > 2019 > 50(5): 572-578. > DOI: 10.11665/j.issn.1000-5048.20190510

ZHANG Shengjie, WANG Li, TIAN Zhimei. Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method[J]. Journal of China Pharmaceutical University, 2019, 50(5): 572-578. DOI: 10.11665/j.issn.1000-5048.20190510

Citation:

PDF (1231 KB)

Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method

More Information

Graphical Abstract

Abstract

Abstract

An HPLC-DAD wavelength switching method(240 nm, 280 nm, 316 nm, 403 nm)was developed for simultaneous determination of seven index components: hydroxysafflor yellow A, paeoniflorin, ferulic acid, salvianolic acid B, kaempferol, formononetin and tanshinone IIA in Naoxintong capsule. The qualities of different batches of Naoxintong capsules were evaluated by statistical analysis. Seven index components in 20 batches of Naoxintong capsules were simultaneously determined by HPLC wavelength switching method with Capcell PAK C₁₈ MG II column(250 mm × 4. 6 mm, 5. 0 μm). The mobile phase consisted of methanol-acetonitrile(25 ∶75, A)-0. 1% formic acid aqueous solution(B)with a gradient elution program and a flow rate of 1. 0 mL/min, and the column temperature was 30 °C. The results were analyzed by statistical analysis to evaluate the differences in the quality of Naoxintong capsules. Results showed that the seven active components were well separated and showed good linearity hydroxysafflor yellow A(403 nm)2. 30- 11. 50 mg/L(r=0. 999 2), paeoniflorin(240 nm)8. 81- 44. 05 mg/L(r=0. 999 6), ferulic acid(316 nm)1. 22- 6. 10 mg/L(r=0. 999 6), salvianolic acid B(280 nm)11. 61- 58. 05 mg/L(r=0. 999 4), kaempferol(403 nm)1. 16-5. 80 mg/L(r=0. 999 4), formononetin(240 nm)0. 12- 0. 60 mg/L(r=0. 999 5)and tanshinone IIA(280 nm)2. 28- 11. 40 mg/L(r=0. 999 5). The precision was good and RSD was less than 2. 0%, The repeatability was good and RSD was less than 2. 0%. The stability was good in 24 h. The average recoveries were between 97. 35%- 101. 02% and RSD was less than 2. 0%. The contents of target components in Naoxintong capsules, hydroxysafflor yellow A was 0. 213- 0. 369 mg/g, paeoniflorin was 1. 535- 3. 217 mg/g, ferulic acid was 0. 153- 0. 236 mg/g, salvianolic acid B was 2. 563- 3. 271 mg/g, kaempferol was 0. 103- 0. 181 mg/g, formononetin was 0. 022- 0. 028 mg/g, and tanshinone IIA was 0. 466- 0. 698 mg/g. HPLC wavelength change and gradient elution method was established for simultaneous determination of seven index components in Naoxintong capsule. The method is accurate, sensitive, reliable, and repeatable, and can be used for the quality control of Naoxintong capsule.
- Naoxintong capsule,
- multi-index composition,
- determination,
- hydroxysafflor yellow A,
- paeoniflorin,
- ferulic acid,
- salvianolic acid B,
- kaempferol,
- formononetin,
- tanshinone IIA

FullText(HTML)

References (23)

References

[1]	Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 1(中华人民共和国药典:一部)[S].Beijing:China Medical Science Press,2015:1301-1302.
[2]	Wang SS,Xu HY,Ma Y,et al.Characterization and rapid identification of chemical constituents of Naoxintong capsules by UHPLC-linear ion trap/Orbitrap mass spectrometry[J].J Pharm Biomed Anal,2015,111:104-118.
[3]	Sun Z,Zhou L,Li ZL,et al.The chemical constituents study of Naoxintong capsules based on UHPLC-Q-Orbitrap HRMS[J].China J Chin Mater Med(中国中药杂志),2018,53(19):1687-1695.
[4]	Li RR.Clinical analysis of Naoxintong capsule in the treatment of acute ischemic cerebral apoplexy[J].J Front Med(医药前沿),2018,8(33):150-151.
[5]	Li WX,Zhang SQ,Zhao YD,et al.Study progress on chemical compounds pharmacological action and clinical application of Naoxintong capsule[J].China J Chin Mater Med(中国中药杂志),2018,43(10):1998-2005.
[6]	Liu YR,Tang ZS,Song ZX,et al.Q-markers in Naoxintong capsules by using multivariable statistical and “components-targets-diseases” network analysis[J].Chin Tradit Herb Drugs(中草药),2018,49(12):2775-2785.
[7]	Su R,Tang ZS,Liu F,et al.HPLC-DAD fingerprint of Naoxintong capsules[J].Cent South Pharm(中南药学),2019,17(1):1-4.
[8]	Su H,He JB,Hou PH,et al.Study on HPLC fingerprint and comtent determination of Naoxintong capsules[J].Hebei Med J(河北医药),2015,37(5):764-767.
[9]	Li J,Bai Y,Bai Y,et al.Pharmacokinetics of caffeic acid,ferulic acid,formononetin,cryptotanshinone,and tanshinone IIA after oral administration of Naoxintong capsule in rat by HPLC-MS/MS[J].Evid Based Complement Alternat Med,2017,2017:1-12.
[10]	Xu HY,Shi Y,Zhang YQ,et al.Identification of key active constituents of Buchang Naoxintong capsules with therapeutic effects against ischemic stroke by using an integrative pharmacology-based approach[J].Mol Biosyst,2016,12(1):233-245.
[11]	Zhang HL,Cui YX,Wang SM,et al.Determination of paeoniflorin in Naoxintong capsules by HPLC[J].J Chin Med(中医学报),2010,25(1):118-119.
[12]	Chen JS,Wang ZY,Chen AH,et al.Determination of protocatechu aldehyde in Naoxintong capsule by HPLC[J].Guide J Tradit Chin Med Pharm(中医药导报),2015,21(22):34-36.
[13]	Zhang LQ,Zhang XM,Wang R,et al.Determination of paeoniflorin in Naoxintong tablet by HPLC[J].Anhui Med Pharm J(安徽医药),2011,15(8):958-959.
[14]	Wang YB.Determination of danshensu in Naoxintong capsules by HPLC[J].Pract J Cardiac Cereb Pneum Vasc Dis(实用心脑肺血管病杂志),2008(5):29-30.
[15]	Wang CJ,Sun BG,Zhang J,et al.Determination of the content of paeoniflorin in Naoxintong capsules by HPLC[J].J Pharm Res(药学研究),2006(3):153-155.
[16]	Li G,Meng FX,Yang,et al.UPLC simultaneous determination of five components in Naoxintong capsules[J].Chin J Pharm Anal(药物分析杂志),2013(3):414-418.
[17]	Wei QY,Xu YJ.Determination of paeoniflorin,ferulic acid,salvianolic acid b and tanshinone ⅡA in Naoxintong capsule by microemulsion electrokinetic chromatography[J].J Anal Sci(分析科学学报),2013,29(2):159-163.
[18]	Li TT,Hai HY,Zhang B,et al.Analysis of hydroxysafflor yellow A and kaempferol in Carthamus tinctorrius L.by Xinjiang and Henan[J].J Liaoning Univ Tradit Chin Med(辽宁中医药大学学报),2017,19(9):67-70.
[19]	Ding LL,Duan CP,Li F,et al.The determination of hydroxysafflor yellow A and kaempferol in Carthamus tinctorrius L.by different collecting time and parts[J].J Shenyang Pharm Univ(沈阳药科大学学报),2015,32(1):65-69.
[20]	Chen FX,Gao R,Zhang BK,et al.Advances in cardiovascular effects of tanshinone ⅡA[J].China J Chin Mater Med(中国中药杂志),2015,40(9):1649-1653.
[21]	Wang JT,Peng DY,Liu JQ,et al.Comparison the contents of tanshinone IIA in Salvia miltiorrhiza of different origin[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2008,14(3):4-5.
[22]	Hu D,Wang GZ.Comparison of tanshinone IIA contents in different parts of Salvia miltiorrhiza[J].Chin Med Mat(中药材),2005,28(1):34-35.
[23]	Zhao XJ,Wang SJ,Wu AL,et al.Study on degradation law of tanshinone ⅡA by heating in Radix Salvia Miltiorrhizae[J].Chin Pharm(中国药业),2009,18(14):23-24.

[1]	CAI Xu, WU Xiaoqian, HAN Lingfei, FENG Feng, QU Wei, LIU Wenyuan. Research progress on natural products regulating osteogenic differentiation[J]. Journal of China Pharmaceutical University, 2025, 56(1): 10-21. DOI: 10.11665/j.issn.1000-5048.2024101003
[2]	LU Ningshu, JI Tao, LU Yinglan, XU Xiyuan, GU Xiaochen, DING Yang. Drug delivery strategies and clinical research progress for encephalopathy[J]. Journal of China Pharmaceutical University, 2024, 55(5): 577-589. DOI: 10.11665/j.issn.1000-5048.2024063001
[3]	YAO Chunlu, ZHANG Weijie, ZHANG Yunlong, DENG Zhaoxia, WANG Mengling, ZHANG Zuoling, WANG Chen, SONG Qinxin, ZOU Bingjie. Progress of single-cell protein imaging methods[J]. Journal of China Pharmaceutical University, 2024, 55(2): 147-157. DOI: 10.11665/j.issn.1000-5048.2024010205
[4]	WANG Chen, ZHANG Zhengping, LI Yinchun. Development strategy and clinical research progress of universal chimeric antigen receptor T-cell drugs[J]. Journal of China Pharmaceutical University, 2023, 54(2): 141-149. DOI: 10.11665/j.issn.1000-5048.20211125001
[5]	LU Zhipeng, XU Qinglong, CHEN Panpan, QIN Yajuan, TANG Lijun, LI Tingyou. Research progress of radioprobes targeting fibroblast activating protein[J]. Journal of China Pharmaceutical University, 2022, 53(6): 651-662. DOI: 10.11665/j.issn.1000-5048.20220603
[6]	YANG Wanwan, YE Fangyu, WU Yujia, WANG Haochen, ZHAO Li. Research progress of PARP inhibitors in cancers and their drug resistance[J]. Journal of China Pharmaceutical University, 2022, 53(5): 525-534. DOI: 10.11665/j.issn.1000-5048.20220503
[7]	WANG Chen, XU Jun, LIU Yanhua, WANG Zengtao, HU Yue, TIAN Taiping, YI Mengjuan. Research progress on functionalized graphene oxide as drug carriers[J]. Journal of China Pharmaceutical University, 2017, 48(1): 117-124. DOI: 10.11665/j.issn.1000-5048.20170118
[8]	ZHANG Danfeng, JIAO Yu, LIU Yong, ZHANG Yanmin, ZHANG Zhimin, LU Tao. Progress of small molecule anti-tumor covalent drugs[J]. Journal of China Pharmaceutical University, 2017, 48(1): 1-7. DOI: 10.11665/j.issn.1000-5048.20170101
[9]	ZHANG Jinghui, WANG Yajing, HU Rong. Roles of Moesin in tumor progression[J]. Journal of China Pharmaceutical University, 2015, 46(3): 371-375. DOI: 10.11665/j.issn.1000-5048.20150319
[10]	Advances and Prospects of Drug Discovery and Development Zhang Yihua, Peng Sixun, Hua Weiyi[J]. Journal of China Pharmaceutical University, 1999, (2): 75-80.

Cited By

Cited by

Periodical cited type(10)

1.	严欣，胡蝶，贾瑞瑞，华雅洁，岳远征，王良桂，杨秀莲. 海州常山组培再生体系的建立. 分子植物育种. 2022(04): 1297-1303 .
2.	郝丽亚，李冰洁，王中林，郑新华. 扯根菜化学成分及其保肝活性. 中成药. 2022(09): 2848-2854 .
3.	张宇，岑银芝，陈亮，李勇军，孙建博，李林珍. 海州常山茎的化学成分研究(Ⅱ). 中药材. 2022(04): 857-861 .
4.	王啸洋，卫柯，陆云阳，佟菲，张艳华，汤海峰. 美花铁线莲茎乙醇提取物正丁醇萃取部位化学成分的提取和鉴定. 环球中医药. 2022(11): 1784-1790 .
5.	李林珍，张宇，陈亮，岑银芝，涂杨丽，杨小生，李勇军. 海州常山茎正丁醇部位的化学成分及体外抗肿瘤活性研究. 中国药房. 2022(21): 2578-2583+2589 .
6.	刘晓聪，林冬梅，刘敏，张敏，李强，王健，徐露琳，高原，杨健. 番石榴的化学成分及其抗肿瘤与抗真菌活性. 中国中药杂志. 2021(15): 3877-3885 .
7.	陈林玉，宋乐园，王云雨，卢梦如，顿彩云，杨青华，毕跃峰. 红小米化学成分与营养成分分析. 食品科学. 2021(18): 218-224 .
8.	张吕丽，吴云飞，李祖强，罗蕾. 柄果海桐化学成分研究(Ⅲ). 云南师范大学学报(自然科学版). 2020(02): 55-58 .
9.	吴威，宋芷琪，田琨宇，张会永. 豨桐丸的本草考证及组方药物化学成分和药理作用研究进展. 中草药. 2020(17): 4586-4597 .
10.	刘璐，张宇，魏茜，李勇军，杨小生，李林珍. 臭梧桐子化学成分研究. 中药材. 2020(07): 1622-1625 .

Other cited types(8)

Get Citation

PDF

XML

Article views (516) PDF downloads (686) Cited by(18)

Turn off MathJax

Article Contents

Abstract

References

Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method

Abstract

References

Related Articles

Cited by

Periodical cited type(10)

Other cited types(8)

Catalog

Simultaneous determination of seven index components in Naoxintong capsule by HPLC wavelength switching method

Abstract

References

Related Articles

Cited by

Periodical cited type(10)

Other cited types(8)

Catalog

Export File

Citation

Format

Content